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Abstract
Synthesis, Characterization, and Reactivity Studies of para-Substituted
Triaryltin Cobaloximes
Elizabeth Marie Ward
Several six-coordinate cobaloxime compounds containing a triaryltin ligand were
synthesized and characterized. These cobaloximes include (4-t-BuPy)Co(DH)2Sn(C6H4-ptolyl)3, (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3, (NH3)Co(DH)2SnPh3, and (4-tBuPy)Co(DH)2Bn. (4-t-BuPy)Co(DH)2Sn(C6H4-p-tolyl)3 crystallized in the
centrosymmetric triclinic space group P-1 (Z=4) with unit cell dimensions a = 13.2949(5)
Å, b = 17.7508(7) Å, c = 18.2240(7) Å, α = 107.1983(13)º, β = 91.6597(13)º, γ =
107.6992(12)º, and Volume = 3880.5(3) Å3. The structure was isostructural with other
alkyl cobaloximes. Preliminary X-ray structure analysis determined that
(NH3)Co(DH)2SnPh3 had a NH3 ligand bound to the six-coordinate octahedral cobalt center
and trans to the triaryltin ligand. The para-substituted cobaloximes were synthesized
through a Gringard reaction to obtain the tetraaryltin species, SnAr4, followed by an
adapted Jolly redistribution procedure to obtain the triaryltin chloride species, ClSnAr3.
The SnAr4 compounds synthesized were Sn(C6H4-p-tolyl)4, Sn(C6H4-p-t-Bu)4, and
Sn(C6H4-p-OCH3)4. The ClSnAr3 complexes synthesized successfully were ClSn(C6H4-ptolyl)3 and ClSn(C6H4-p-t-Bu)3. These ClSnAr3 complexes were used as the tin ligand to
synthesize the corresponding cobaloxime compounds. Once synthesized, the cobaloximes
underwent halogen cleavage titrations to investigate the effects of changes in the
cobaloxime coordination environment and to compare their reactivity to that of the
CoIII(OEP)SnPh3. The multiple products formed through these halogen cleavage reactions
indicates that the Co-Sn bond is not cleaved cleanly for these cobaloximes, unlike the
porphyrins compounds. The cobaloximes react with the halogens to first cleave the Sn-C
bonds through electrophilic aromatic substitution, indicating that cleavage of the Sn-C
bond is more facile than cleavage of the Co-Sn bond in these compounds.
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1.0 Introduction
1.1 Thesis Overview
The objective of this thesis project is to develop a cobaloxime with a Co-Sn bond that will
exhibit clean cleavage through oxidation with halogen. The cobaloxime environment will be
tuned in order to gain more insight into the structure and possibly the reactivity of the
cobaloxime. This project involves changing the substituents on the phenyl ring of the triaryltin
group of the cobaloxime and also work on modifying the Lewis base ligand and attempts to
change the group 14 element bound to the cobalt center. The setup of this thesis begins with an
introduction into the history of vitamin B12, its structure, work done to investigate factors
affecting the Co-C bond, model compounds for vitamin B12, and work done by the Stolzenberg
group that provides the basis for this project. Following the introduction, the experimental
section will cover the synthesis of the compounds used in this project. Finally, the results and
discussion and concluding remarks are presented.
1.2 Project Background
Vitamin B12 (cyanocobalamin), seen in Figure 1 with R = CN, is a bioinorganic naturally
occurring molecule that has been investigated by many different disciplines such as medicine,
agriculture, biochemistry, microbiology, organic and inorganic chemistry, X-ray crystallography,
theoretical chemists, etc.1 The interest in vitamin B12 has its beginnings in medicine as a
treatment for pernicious anemia in the 1920’s using liver therapy. The use as a therapy preceded
the isolation of the compound in 1948 by Folkers at Merck and by Smith and Parker at Glaxo
Laboratories. 2-4 Following this, the coenzyme was isolated in 1958 by Barker and associates.5
The majority of the structure was unknown, but the X-ray crystal structure was solved in 1961 by
1

Dorothy Hodgkin. Her work revealed the presence of two structures that were previously
unknown in nature: the corrin ring (seen in Figure 2) and the Co-C bond which was the first
known naturally occurring organometallic compound.1 This relatively inert bond between cobalt
and a primary alkyl ligand is especially interesting due to its stability under physiological
conditions.6

Figure 1: General Cobalamin Structure where R = 5’deoxyadenosyl, CN, or Me

Vitamin B12 belongs to a class of compounds called cobalamins, where the heterocyclic
base is 5,6-dimethylbenzimidazole. Figure 1 above shows the structures of vitamin B12 also
known as cyanocobalamin (CNCbl, R=CN), adenosylcobalamin (AdoCbl, R=5’-deoxyadenosyl),
and methylcobalamin (MeCbl, R=Me).7-8 The six-coordinate cobalt atom exhibits an octahedral

2

structure that is bound axially by the R group, nitrogen on the benzimidazole, and by four donor
nitrogen atoms of the corrin ring in the equatorial plane. The six-coordinate arrangement exhibits
a tetragonal distortion and the corresponding splitting pattern of the d-orbitals is observed.6 The
corrin ring, conjugated system of double bonds, creates a strong ligand field resulting in low spin
cobalt and differs slightly from the more widely known porphyrin ring by directly binding two of
the rings, as seen in Figure 2.9-10 The four donor nitrogen atoms of the corrin ring are not
coplanar with the cobalt atom, as is seen in the porphyrin complex.7 The Co-N bond to the
benzimidazole is longer than the Co-N bonds in the equatorial plane. The cleavage of the Co-C
bond is important in the enzymatic reactions of the coenzymes. The Co-C bond is stable towards
hydrolysis, but still weak enough to be cleaved readily by enzymatic reactions. This interesting
behavior led chemists to study these complexes and the reactivity of the metal-alkyl bond
specifically.7, 11-12

Figure 2: Corrin ring (left) versus porphyrin ring (right)

To understand the enzymatic reactions of the coenzymes, it is important to gain
understanding into the Co-C bond and how readily it gets cleaved. This led to investigating the
variability of the Co-C bond length and what factors affect it, such as the nature of the axial

3

ligands trans to each other. In order to more easily probe the structure of the cobalamins, model
compounds were developed and a sampling of those models including Schiff bases such as
Co(Saloph)R and Co(Salen)R, alkyl cobalt porphyrins, and cobaloximes (seen in Figure 3).

Co

Co

O

N

N

N

N

R
O

R

O

O

Co(Salen)R

Co(Saloph)R

R
O

H O
N

N
Co

N

N
O

H O
Base

Figure 3: Models for the cobalt center of Vitamin B12

In 1964, Schrauzer and Kohnle introduced cobaloximes, named for their similarities to
cobalamins with the general form (Base)Co(DH)2R, where DH is the dimethylglyoxime ligand
(seen in Figure 3). 13 These Co(III) complexes consist of two dimethylglyoxime ligands
(abbreviated DMG) that are linked through O—H⸱⸱⸱O hydrogen bonds. The axial positions
include an alky group (R) and an electron donating Lewis base trans to it. The first alkyl
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cobaloxime was studied by Lenhert in 1967 and has the structure (Py)Co(DH)2CH2COOCH3. It
was characterized by X-ray crystallography to confirm the structure of the cobaloxime and
compare the bond distances and angles to the coenzyme. 14 The four donor nitrogen atoms lie in
the plane with the Co atom, as opposed to the slightly distorted plane of the cobalamins. The
equatorial Co-N bond distances of the cobaloxime averaged 1.88 Å, very similar to the
coenzyme (1.90 Å). The axial bond lengths for the Co-N and Co-C in the cobaloxime are both
~2.04 Å, whereas the Co-C and axial Co-N of the coenzyme are 2.03 Å and 2.24 Å respectively.
The axial Co-N bond in the cobaloxime is significantly shorter than that of the coenzyme,
resulting from the slightly more positive cobalt center in the cobaloxime.7 Among the series of
synthesized cobaloximes, the DMG ligands and cobalt atom have similar bond lengths and
angles with some variability in the bridging H location, but the lengths to the axial substituents
will vary greatly.
The main reason for this variability in the axial bond lengths is the trans effect.15-17 This
arises from the effect of the axial electron donating base on the axial alkyl group and resulting
Co-C bond trans to it. This effect can be seen in the cobalamins and the changes in the axial CoN bond of the benzimidazole. When the group trans to benzimidazole is the CN group of vitamin
B12 the bond length is 1.97 – 2.06 Å, but when the group trans to the benzimidazole is the
adenosyl group of AdoCbl the Co-N bond length is 2.24 Å, indicating a weaker bond to the
benzimidazole. This could indicate that when the bond from the cobalt center to the
benzimidazole is replaced upon binding to the protein, the nature of the group (side chain on
protein) that binds the cobalt could control the cleavage of the Co-C bond trans to it through its
electron withdrawing properties.

5

This trans effect was studied further through cobalamin models. Elder and coworkers
investigated this effect first using pentammine cobalt complexes, [Co(NH3)5X] and found that
the equatorial Co-N bonds were similar in length to the cobalamins, but the axial Co-N bond
length depends on the nature of the X ligand trans to it.18-22 Elder and coworkers then extended
their work to cobaloximes and found a correlation between the structural and kinetic trans effects
indicating bond lengthening could correlate to reactivity. Randaccio and Marcilli analyzed
several series of cobaloximes and their geometries. They found that for the same phosphine,
(PPh3)Co(DH)2X for example, as the σ donating ability of the trans ligand increases the Co-P
bond will shorten with X being electron withdrawing and will lengthen with X being electron
donating.23 They also found that the substituents on the C of the alkyl group attached to the
cobalt can also have trans influencing effects, with an electron withdrawing substituent
weakening the trans influence and an electron donating substituent strengthening the trans
influence. Also they found that in the series of cobaloximes, the nature of the base will also
effect the trans influence, with P-donor Lewis bases having a greater influence than the N-donor
Lewis bases.
Sterics can also affect the bond lengths of the axial alkyl group and base to the cobalt
center. In cobaloximes, non-bulky axial ligands will allow the Co atom to sit nearly coplanar
with the four donor nitrogen atoms. Bulky axial ligands will displace the cobalt atom from the
plane of the DMG ligands, moving the cobalt towards the bulky ligand and bending the DMG
ligands away from the bulky axial ligand.7 In phosphine cobaloximes, for the same axial trans
ligand, the length of the Co-P bond will fall between 2.165 – 2.418 Å.24 The effects of increasing
the bulk (cone angle) of the phosphine ligand were that the Co-P bond lengthens, the cobalt atom
displaces toward the P, also the Co-C bond will lengthen with the increase in the bulk of the
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phosphine ligand trans to it. Marzilli, Randaccio and coworkers were able to demonstrate a linear
relationship between the length of the Co-C bond and the number of non-hydrogen substituents
on the C of the alkyl group bound to the cobalt center in (Py)Co(DH)2X cobaloximes.23 Ohashi
found similarly that this lengthening will also occur with substituents that are not simple alkyl
groups, but the relationship will be exponential instead of linear. To summarize the effects of
steric bulk on the alkyl-cobalt bond: small axial ligands will lead to a short Co-C and the cobalt
ion being coplanar with the DMG ligands, a bulky base will cause the DMG ligands to bend
towards the alkyl group and lengthen the Co-C slightly, and lastly a bulky substituent on the
alkyl group bound to carbon leads to a lengthening of the Co-C bond and an increase in the CoC-R bond angle due to an increase in steric interactions between the R substituent and the DMG
ligands. This increase in substituent bulk leading to the lengthening of the Co-C bond is also
seen in the Co-CH2-C bond angle in the coenzyme B12 with analogous steric interactions with the
corrin ring. These steric interactions cause strain and therefore help promote the cleaving of the
Co-C bond.
1.3 Basis of Current Project
Stolzenberg has done extensive research involving the synthesis, characterization, and
reactivity studies of organocobalt porphyrins.25-29 These organocobalt porphyrins can also be
used as models for vitamin B12. The reactivity of the Co-E bond, where E is a group 14 element,
was investigated. In 2001, Cao and Stolzenberg synthesized CoIII(OEP)SnPh3, where OEP is
octaethylporphyrin, and found that it was unexpectedly inert when compared to the alkyl
porphyrin. The synthesis of the porphyrin is seen in Scheme 1. This stability of the
CoIII(OEP)SnPh3 raises questions about why the Co-Sn bond is stronger than the Co-C bond in
this system. The CoIII(OEP)SnPh3 has a slow rate of homolysis and is stable to thermal

7

decomposition. The Co-Sn bond of the porphyrin can be readily cleaved by oxidation with a
halogen or photolysis (Scheme 1).

CoII(OEP)

NaHg

CoI(OEP)

-

Ph3SnCl

CoIII(OEP)SnPh3

I2

CoIII(OEP)I

Ph3SnI

III

Scheme 1: Synthesis of Co (OEP)SnPh3 and its oxidation with Iodine

The interesting reactivity of the porphyrins prompted investigation into bond strengths of
the group 14 analogues. With this in mind, a larger quantity of material would be needed to
perform the necessary experiments and with the low yield syntheses of the organocobalt
porphyrins, this was not feasible. The switch to cobaloximes, another vitamin B12 model came
after finding a series of compounds synthesized by Schrauzer of the form (Py)Co(DH)2EPh3,
where E = Si, Ge, Sn, and Pb.30-31 He reported the complexes to have good thermal and moderate
air stability, for the tin and lead cobaloximes, but the reactivity of these compounds was not
investigated. In 2007, Stolzenberg and co-workers.32 synthesized the 4-t-BuPy analogues of the
SnPh3 and PbPh3 cobaloximes and were able to obtain crystal structures and some reactivity data
for them. The 4-t-butylpyridine (4-t-BuPy) was used in placed of pyridine (Py) to improve
solubility and simplify the 1H NMR spectra of the synthesized compounds.33-35 The germanium
and silicon analogues were unable to be synthesized due to poor solubility and other issues.
Halogen cleavage reactions were performed on the (4-t-BuPy)Co(DH)2SnPh3 and the (4t-BuPy)Co(DH)2PbPh3 and found that clean cleavage of the Co-E bond did not occur. This
outcome is very different from the reaction of the organocobalt porphyrin with halogen. This
difference in reactivity of the porphyrin and cobaloxime complexes containing Co-Sn bonds is
the basis for this project. The goal of this work is to find a cobaloxime system that, through
tuning of the ligand environment, will exhibit clean Co-Sn bond cleavage and provide insight
8

into the differences in reactivity of these two cobalamin model compounds. There are several
ways to change the ligand environment to tune the reactivity: changing the size or strength of the
base, changing the group 14 element (E) bound to the cobalt center, changing the substitution on
the triaryltin ligand, or looking into another 5 coordinate system (like Schiff bases or a labile
base that can be easily removed to form a 5 coordinate cobaloxime) to compare to the 5
coordinate porphyrin. The approach that is taken in this project is to change the substitution of
the triaryltin ligand by adding a substituent to the para position of the phenyl ring. Our
hypothesis is that the halogen is cleaving the Sn-C on the phenyl ring as opposed to the desired
Co-Sn bond cleavage and that by substituting onto the para position of the phenyl ring may
change the donor strength enough to promote Co-Sn cleavage. To test this hypothesis,
tetraaryltin compounds were synthesized with -CH3, -OCH3, and -tBu substituted in the para
position of the phenyl ring. The next step was to perform a redistribution reaction to obtain the
substituted chloro triaryl tin compounds which were then reacted with (4-t-BuPy)Co(DH)2Cl to
form the desired cobaloximes. The cobaloximes then underwent halogen cleavage reactions and
their products analyzed.
2.0 Experimental
2.1 Materials and Methods
All reactions were carried out under a nitrogen atmosphere using Schlenk techniques, unless
otherwise noted. The Co(DH)(DH2)Cl236, (Py)Co(DH)2SnPh3, (4-t-BuPy)Co(DH)2Cl36, and (4-tBuPy)Co(DH)2SnPh332, 37 were prepared using literature methods. The cobaloxime (4CNPy)Co(DH)2SnPh3 was previously synthesized by a member of the Stolzenberg group. The
cobalt ammine complex, [Co(NH3)5Cl]Cl2, was synthesized in the Inorganic Synthesis lab
(Chem 423) at West Virginia University, but is available commercially. All solvents and
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compounds used in the syntheses were reagent grade or the best available. All commercially
available compounds were used as received. Deuterated solvents, CDCl3, C6D6, DMSO and
CD3CN, were passed through a column of activated alumina prior to use. 1H NMR spectra were
recorded on a JEOL Eclipse 270 MHz, Agilent 400 MHz, and Varian INOVA 600 MHz NMR
spectrometers. The chemical shifts (δ) are given in parts per million and referenced to internal
TMS (0 ppm) or residual protio solvent (7.26 for CDCl3, 7.16 for C6D6, 2.50 for DMSO and 1.94
for CD3CN). The GC/MS samples were run in benzene and the commercial compounds 1bromo-4-tertbutylbenzene, 4-bromotoluene, and 4-iodotoluene were run under the same
conditions to compare the retention times to our compounds.
2.2 Syntheses
2.2.1

Synthesis of tetraaryltin complexes, SnAr4

The tetraaryltin complexes have four para-substituted phenyl rings attached to a tin
center. The substituents used on the phenyl rings are p-tolyl (-CH3), p-anisole (-OCH3), and ptertbutyl (-t-Bu). The three compounds were synthesized using the same procedure and 1H NMR
shifts and melting points of the recrystallized compounds were consistent with literature values.
The following procedure was used for the synthesis of Sn(C6H4-p-tolyl)4.
This synthesis was carried out under nitrogen using Schlenk techniques and the glassware
and magnesium turnings were oven dried overnight to limit moisture exposure during the
Grignard reaction. A combination of 12.26 g of 4-bromotoluene and 1.77 g of magnesium
turnings were added to 105 mL of THF. An addition funnel attached to the reaction flask
contained a portion of the 4-bromotoluene and 25 mL of THF. The reaction was brought up to
reflux and the contents of the addition funnel were added slowly, along with two crystals of I2.
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Upon addition of the iodine, the solution turned orange-brown, then slowly lightened in color as
the reaction heated up until the color finally dissipated and a colorless solution remained. The
solution was held at reflux for three hours. The procedure calls for the solution to be transferred
under nitrogen away from any unreacted magnesium, but there was no unreacted magnesium at
this point. The flask was cooled in an ice bath and 1.26 mL of SnCl4 was added through the top
of the reflux condenser. Some white smoke was observed upon addition, along with some white
solid (MgCl2) on the top of the liquid when the ice bath was removed. The flask was heated back
to reflux and allowed to reflux. After 20 hours of reflux, an amber colored liquid was observed.
Upon addition of 35 mL of 1 M HCl, the solution turned white and then heated slightly. The
white solid dissolved and left an amber colored liquid layer on top and a colorless clear layer on
the bottom of the flask. The flask was placed in ice and after about 20 minutes, a white solid
began to form at the interface between the two liquid layers. As the flask remained in the ice
longer, more solid began to form. The flask was placed in the freezer overnight to facilitate
product formation. The solution was filtered and the filtrate saved for a second crop. The filtered
solid was washed with 25 mL of methanol, followed by 50 mL of 1 M HCl and another 25 mL of
methanol. 1.65 g of white solid was collected for crop 1. From the second crop, another 1.88 g of
white solid was obtained. Crop 1 was recrystallized from warm toluene layered with ethanol. Its
melting point was 235.3 – 236.4 ºC, which is consistent with literature. The 1H NMR is also
consistent with literature values. (67% yield) 1H NMR (CDCl3): δ 2.37 (s, 12 H), 7.21 (dd, 8 H),
7.49 (dd, 8 H)
Sn(C6H4-p-OCH3)4: (39% yield) 1H NMR (CDCl3): δ 3.80 (s, 12 H), 6.87 (dd, 8 H), and 7.39
(dd, 8 H)
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Sn(C6H4-p-tBu)4: (47% yield) 1H NMR (C6D6): δ 1.23 (s, 27 H), 7.33 (dd, 8 H), and 7.75 (dd, 8
H)
2.2.2

Synthesis of chlorotriaryltin complexes, ClSnAr3

The tetraaryltin complexes undergo a redistribution in order to obtain the chlorotriaryltins.
The following procedure details the synthesis of ClSn(C6H4-p-t-Bu)3. The same procedure was
used to synthesize ClSn(C6H4-p-tolyl)3 with similar observations, but redistribution attempts of
ClSn(C6H4-p-OCH3)3 were unsuccessful.
ClSn(C6H4-p-t-Bu)3 was synthesized using 1/20 of the quantities from the Jolly procedure.38
A mass of 1.60 g (0.0025 mol) Sn(C6H4-p-t-Bu)4 was combined with 0.1 mL (0.00085 mol)
SnCl4 in the reaction tube and placed in an oil bath. The temperature was raised to 230 ºC over a
45-minute period. The temperature remained at 233 ºC for three hours. After this time, the
mixture in the reaction tube had dissolved. The temperature was dropped to 100 ºC and the
solution was poured into a beaker and allowed to cool to room temperature. The tan solid was
broken up after cooling and stirred with 200 mL of ethanol at ~ 50 ºC. About 500 mL of water
was added slowly to the ethanolic solution and a white solid crashed out of solution. The flask
was placed in a refrigerator for 30 minutes to promote solid formation. The solid was filtered and
a relatively pure compound was obtained. (67% yield) 1H NMR (C6D6): δ 1.19 (s, 27 H), 7.30
(dd, 6 H), and 7.70 (dd, 6 H)
ClSn(C6H4-p-tolyl)3: (61% yield) 1H NMR (C6D6): δ 2.04 (s, 9 H), 7.02 (dd, 6 H), 7.62 (dd, 6 H)
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2.2.3

Synthesis of (NH3)Co(DH)2Cl

In an Erlenmeyer flask, 4.00 g of dimethylglyoxime (DMG), 5.02 g [Co(NH3)5Cl]Cl2, 40
mL of water and 15.04 g of ammonium acetate were combined and stirred. Approximately 2 mL
of concentrated acetic acid was added to the flask. The flask was then heated in a water bath,
keeping the temperature below 100 ºC. After five minutes, the solution turned brown and NH3
gas was detected by litmus paper. More acetic acid was added to the flask, about 8 mL in total,
until no more ammonia gas was able to be detected. The flask continued to heat to dissolve the
DMG. After 10 minutes, the solution was filtered and the filtrate was reduced to a small volume.
The filtrate was filtered and the solid was combined with the previous crop of solid and washed
with cold distilled water. The solid was then heated in 25 mL of ethanol to remove the
undissolved DMG. The solution was filtered, and the crude solid was allowed to air dry. The
crude product was then recrystallized from hot water with a drop of acetic acid. Crop one
resulted in 3.00 g of product and the 1H NMR was obtained. Crop two resulted in 0.75 g of
brown needles. (55% yield) 1H NMR (DMSO): δ 1.92 (s,3 H), 2.27 (s, 12 H), and 18.46 (s, 2 H)
2.2.4

Synthesis of Cobaloximes Using One-Step Synthesis

The one-step cobaloxime procedure was used to synthesize (NH3)Co(DH)2SnPh3 and (4t-BuPy)Co(DH)2Bn.39 For the synthesis of the benzyl cobaloxime, benzyl chloride was used
instead of ClSnPh3.
In a Schlenk flask 1.0 g (NH3)Co(DH)2Cl, 1.0 g ClSnPh3 and 20 mL of a 1:1 (v:v)
methanol and water solution were combined and stirred. The flask was degassed and backfilled
with nitrogen. Over a period of 15 minutes, 0.52 g of NaBH4 was added to the flask in 3
portions. Upon addition of the NaBH4, the solution turned a reddish brown color. After 10
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minutes, the solution was filtered and washed with methanol and the filtrate set aside. The solid
was washed with ether and hexanes and 0.58 g of orange solid product was obtained in crop one.
The second crop crashed out of the filtrate upon sitting and was filtered, washed with ether and
hexanes, and the 0.43 g of lighter orange solid product was obtained. (50 % yield) 1H NMR
(C6D6): δ 0.13 (s, 3 H), 1.66 (s, 12 H), 7.13 (m, 4 H), 7.60 (m, 2 H), 7.78 (dd, 6 H), 19.20 (br., 2
H)
(4-t-BuPy)Co(DH)2Bn: (62 % yield), 1H NMR (C6D6): δ 0.64 (s, 9 H), 1.73 (s, 12 H), 3.32 (s, 2
H), 6.55 (dd, 2 H), 6.98 (t, 2 H), 7.03 (dd, 1 H), 7.39 (dd, 2 H), 8.83 (dd, 2 H), 19.52 (s, 2 H)
2.2.5

Synthesis of Cobaloximes Using Regular Synthesis32, 36-37

These compounds were synthesized using the same procedure as the previously reported (4-tBuPy)Co(DH)2SnPh332, 37 using (4-t-BuPy)Co(DH)2Cl36 synthesized from literature methods and
the ClSn(C6H4-p-tolyl)3 and ClSn(C6H4-p-t-Bu)3 obtained from the redistribution procedure
outlined in the above section.
(4-t-BuPy)Co(DH)2Sn(C6H4-p-tolyl)3: (56% yield) 1H NMR (CDCl3): δ 1.25 (s, 9 H), 1.72 (s, 12
H), 2.30 (s, 9 H), 7.09 (dd, 6 H), 7.25 (dd, 2 H), 7.39 (dd, 6 H), 8.40 (dd, 2 H), 18.56 (br, 2 H)
(4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3: (59% yield) 1H NMR (C6D6): δ 0.64 (s, 9 H), 1.22 (s, 36
H), 1.63 (s, 12 H), 6.56 (dd, 2 H), 7.28 (dd, 6 H), 7.95 (dd, 6 H), 8.92 (dd, 2 H), 19.74 (br, 2 H)
2.3 X-ray Structure Analysis
2.3.1

Analysis for (4-t-BuPy)Co(DH)2Sn(C6H4-p-tolyl)3

A light orange crystal of (4-t-BuPy)Co(DH)2Sn(C6H4-p-tolyl)3 was washed with the
perfluoropolyether PFO-XR75 (Lancaster) and wedged in a glass capillary. The sample was
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optically aligned on a Bruker AXS D8 Venture fixed-chi X-ray diffractometer equipped with a
Triumph monochromator, a Mo Kα radiation source (λ = 0.71073 Å), and a PHOTON 100
CMOS detector. Two sets of 12 frames each were collected using the omega scan method with a
10 s exposure time. Integration of these frames followed by reflection indexing and leastsquares refinement produced a crystal orientation matrix for the triclinic crystal lattice.
Data collection consisted of the measurement of a total of 1840 frames in five runs using omega
scans with the detector held at 5.00 cm from the crystal. The total exposure time was 10.22 hours.
Frame scan parameters are summarized in Table 1 below:
Table 1: Data collection details for (4-t-BuPy)Co(DH)2Sn(C6H4-p-tolyl)3.
Run

2θ

ω

φ

χ

Scan Width (º)

Frames

Exposure Time
(sec)

1

11.01 -170.99 144.00

54.74

0.50

368

20.00

2

11.01 -170.99

54.74

0.50

368

20.00

3

11.01 -170.99 -144.00

54.74

0.50

368

20.00

4

11.01 -170.99 -72.00

54.74

0.50

368

20.00

5

11.01 -170.99

54.74

0.50

368

20.00

0.00

72.00

The APEX2 software program (version 2014.1-1)40 program was used for diffractometer
control, preliminary frame scans, indexing, orientation matrix calculations, least-squares
refinement of cell parameters, and the data collection. The frames were integrated with the Bruker
SAINT software package using a narrow-frame algorithm. The integration of the data using a
triclinic unit cell yielded a total of 97231 reflections to a maximum θ angle of 27.50° (0.77 Å
resolution), of which 17647 were independent (average redundancy 5.510, completeness = 99.0%,
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Rint = 5.76%, Rsig = 5.79%) and 11275 (63.89%) were greater than 2σ(F2). The final cell constants
of a = 13.2949(5) Å, b = 17.7508(7) Å, c = 18.2240(7) Å, α = 107.1983(13)°, β = 91.6597(13)°, γ
= 107.6992(12)°, volume = 3880.5(3) Å3, are based upon the refinement of the XYZ-centroids of
9877 reflections above 20 σ(I) with 4.703° < 2θ < 54.95°. Data were corrected for absorption
effects using the multi-scan method (SADABS). The ratio of minimum to maximum apparent
transmission was 0.701. The calculated minimum and maximum transmission coefficients (based
on crystal size) are 0.659 and 0.885.
The structure was solved by direct methods and difference Fourier analysis using the programs
provided by SHELXL-2013.41 The crystallographic asymmetric unit contains two independent
molecules of the cobalt complex. Idealized positions for the hydrogen atoms were included as
fixed contributions using a riding model with isotropic temperature factors set at 1.2 times
(aromatic hydrogens) or 1.5 (methyl hydrogens) times that of the adjacent carbon atom. The
positions of the methyl hydrogen atoms were optimized by a rigid rotating group refinement with
idealized angles. The fractional coordinates and the isotropic thermal parameters of the two Obound hydrogen atoms in each molecule were refined. The t-butyl substituent containing carbon
atoms, C52-C55, suffers from a two-site Star-of-David disorder. The fractional coordinates and
anisotropic thermal parameters for C53, C54, and C55 in both sites were independently refined
with the six C52-C(methyl) distances restrained to 1.52 ± 0.01 Å. Full-matrix least-squares
refinement, based upon the minimization of Σwi |Fo2 - Fc2|2, with weighting wi-1 = [σ2(Fo2) +
(0.0160 P)2 + 6.5059 P], where P = (Max (Fo2, 0) + 2 Fc2)/3.2 The final anisotropic full-matrix
least-squares refinement on F2 with 950 variables converged at R1 = 6.47%, for the observed data
and wR2 = 9.56% for all data. The goodness-of-fit was 1.103. The values of R1, wR2, and the
goodness-of-fit (GOF) were determined using the following equations: R1 = Σ(||Fo| - |Fc||) / Σ |Fo|,
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wR2 = [Σ [w(Fo2 - Fc2)2] / Σ [w(Fo2)2]]1/2, and GOF = [Σ [w(Fo2 - Fc2)2] / (n-p)]1/2, where n
is the number of reflections and p is the total number of parameters which were varied during the
last refinement cycle.
A correction for secondary extinction was not applied. The largest peak in the final difference
electron density synthesis was 1.054 e-/Å3 and the largest hole was -0.657 e-/Å3 with an RMS
deviation of 0.091 e-/Å3. The linear absorption coefficient, atomic scattering factors, and
anomalous dispersion corrections were calculated from values found in the International Tables
of X-ray Crystallography.42
2.3.2

Preliminary X-ray Analysis for (NH3)Co(DH)2SnPh3

An X-ray structural analysis was also performed to confirm the molecular structure and
composition of (NH3)Co(DH)2SnPh3. However, the quality of the structural analysis was limited
by the presence of unidentified disordered solvent molecules in the lattice. The analysis was
sufficient to establish the atom connectivity and coordination of NH3.
2.4 Halogen Cleavage Titrations
Halogen cleavage titration reactions were completed for the following compounds:
(Py)Co(DH)2SnPh3, (4-t-BuPy)Co(DH)2SnPh3, (NH3)Co(DH)2SnPh3, (4-CNPy)Co(DH)2SnPh3,
(4-t-BuPy)Co(DH)2Sn(C6H4-p-tolyl)3, and (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3. A former
group member also ran a halogen cleavage titration with (4-t-BuPy)Co(DH)2Sn(n-Bu)3. In
general, the halogen used was either I2 or Br2.
The first step was to determine how many equivalents of halogen would be desired for each
sample (for example 0, 0.25, 0.5, 0.75, 1 and 2 equivalents of halogen) and calculate the amount
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of cobaloxime required to end up with approximately 5 mg of sample in each NMR tube. The
cobaloxime was dissolved in a deuterated solvent and diluted to a known volume in a volumetric
flask. This gave the known concentration of the cobaloxime and 1 mL of this solution was placed
in every test tube. The sample of the bromine or iodine was prepared in deuterated solvent and
diluted to a known volume in a volumetric flask. The amount of halogen sample for 0.25
equivalents was calculated and the samples prepared by adding the necessary aliquots of halogen
to the 1 mL cobaloxime samples to get 0, 0.25, 0.5, 0.75, 1, and 2 equivalents of halogen in the
test tubes. For each test tube, 100 µL of solution was removed and used to prepare a GCMS
sample. The remaining 900 µL were transferred to an NMR tube and the proton spectra obtained
for each titration sample. The 1H NMR data was then analyzed to determine how many products
arose as the titration of the halogen progressed to higher equivalents.
3.0 Results and Discussion
This section discusses the synthesis of the compounds used in this project, the X-ray
structure analysis performed, and the results from the halogen cleavage titrations of the
cobaloximes. The syntheses that are covered in this section include: Grignard synthesis of the
tetraaryltin complexes, the successful and unsuccessful attempts at redistribution of the
tetraaryltin species to obtain the chlorotriaryltin complexes, and the synthesis of the cobaloximes
using the chlorotriaryltin complexes. It also discusses the basic synthesis of cobaloximes, the one
step synthesis of the (NH3)Co(DH)2SnPh3 and (4-t-BuPy)Co(DH)2Bn, and previously
synthesized compounds.
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3.1 Synthesis and Characterization of Compounds
3.1.1

Synthesis of Cobaloximes

The Tada method for synthesis of cobaloximes was adapted for the synthesis of (4-tBuPy)Co(DH)2SnPh3 by Stolzenberg, et. al.32, 37 The synthesis of this cobaloxime is described in
Scheme 2. The procedure begins with the reaction of cobaltous chloride hexahydrate with
dimethylglyoxime (DMG) in acetone under aerobic conditions, resulting in Co(DH)(DH2)Cl2
crashing out as the major product.36 The dichloro cobaloxime is then suspended in methanol
under aerobic conditions and heated to about 60 ºC with stirring. This suspension is then mixed
with tri-n-butyl amine that helps to dissolve the dichloro cobaloxime and deprotonate the
cobaloxime before the base is added. The base, 4-t-butylpyridine (4-t-BuPy), is then added to the
solution along with a little water. We chose to use 4-t-BuPy instead of the more common
pyridine due to the improved solubility of these compounds with this base and the simplification

CoCl2 • 6 H2O +

H
O

H
N

N

Acetone

1) MeOH, heat
2) tri-n-butyl amine
3) 4-tertbutylpyridine
Co(DH)(DH2)Cl2

O

Cl
O

SnPh3

H O

N

O
N

1) in MeOH, under N2
2) 4.4 M NaOH, NaBH4

N

N

3) ClSnPh3
4) florisil column

N

Co
N
O

H O
N

H O
N
Co
N

O

H O
N

Scheme 2: Synthesis of (4-t-BuPy)Co(DH)2SnPh3
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of the 1H NMR spectra.33-35 The product crashes out of solution slowly overnight and can then be
recrystallized before the final step of the synthesis.
The (4-t-BuPy)Co(DH)2Cl is then dissolved in methanol under a nitrogen environment and
placed in an ice bath. The solution of 4.4 M NaOH is added to help deprotonate the cobaloxime
and reduce the amount of NaBH4 needed during the reaction. This smaller amount of sodium
borohydride helps to prevent the production of hydrogen gas in the reaction. The cobalt center
then reduces to Co(I) upon the addition of sodium borohydride and the chlorotriphenyl tin is then
added. The reaction flask is covered in aluminum foil to exclude light during the reaction. After
removing the ice bath, the flask is allowed to stir and come to room temperature overnight.
During this time, the (4-t-BuPy)Co(DH)2SnPh3 is formed. The compound is extracted in
dichloromethane, dried and the solvent removed by vacuum to obtain the crude product. The
crude product is then run through a florisil column using a 4:1 dichloromethane: ethyl acetate
eluting solvent system. The product is obtained as orange-red crystals. About 60% yield is
expected based on the limiting chlorotriphenyltin.
CoII(OEP)

NaHg

CoI(OEP)

Ph3SnCl

-

O

H O

N

N
X2
(I2 or Br2)

Co
N
O

Ph3SnI

H O

O
N

N

CoIII(OEP)I

X

R

N

I2

CoIII(OEP)SnPh3

+
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N

N

H O

R-X

H O

O

Base

Base

X
X2
X

Sn

Sn

Co(DH)2

Co(DH)2

Base

Base

+

Scheme 3: Halogen cleavage of Co(OEP)SnPh3 versus (base)Co(DH)2SnPh3
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Upon reaction with halogen (I2 or Br2), (4-t-BuPy)Co(DH)2SnPh3 formed multiple products
in the 1H NMR. This means that the cobaloxime is not reacting the same way as the porphyrin in
regards to Co-Sn bond cleavage with halogen. The halogen cleaves the Co-Sn bond of the
Co(OEP)SnPh3 cleanly, as seen in Scheme 3, but the triphenyl tin cobaloxime does not. The
halogen is cleaving the Sn-C bond through electrophilic aromatic substitution instead of
homolytically cleaving the desired Co-Sn bond.
The project then progressed to explore modifying the coordination environment of the
cobalt. One way that this was explored was through attempts to change the group 14 element
from tin to germanium, silicon, or lead. The lead analogue was previously synthesized and
characterized in the group, but the germanium and silicon analogues are inaccessible in our
hands. In attempts to obtain the germanium analogue, benzyl cobaloxime was synthesized in
order to react with HGePh3 to form toluene and (4-t-BuPy)Co(DH)2GePh3. The synthesis of
benzyl cobaloxime, (4-t-BuPy)Co(DH)2Bn, and the proposed synthesis of (4-tBuPy)Co(DH)2GePh3 is seen in Scheme 4. The benzyl cobaloxime is synthesized through a onestep procedure.39 The (4-t-BuPy)Co(DH)2Cl and benzyl chloride are mixed in a methanol and
water solution under nitrogen. The cobaloxime is reduced by NaBH4 which is added slowly in
several portions over about 15 minutes. The solution is allowed to stir and react for a few more
minutes and then can be isolated through vacuum filtration and washed with ether and hexanes.
The orange product is obtained in approximately 50% yield. The 1H NMR is consistent with the
structure. Although reactions of benzyl cobaloxime and HGePh3 were unable to produce isolable
(4-t-BuPy)Co(DH)2GePh3, the procedure seems like a promising avenue to explore in the future.
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Scheme 4: Synthesis of benzyl cobaloxime and synthetic attempt to synthesize (4-tBuPy)Co(DH)2GePh3
Another modification to the coordination environment of the cobalt that was explored
was altering the Lewis base. Attempts to synthesize (2-MePy)Co(DH)2Cl, (4-MePy)Co(DH)2Cl,
and (2,6-dimethylpyridine)Co(DH)2Cl were unsuccessful, but the synthesis of (NH3)Co(DH)2Cl
was successful. This compound was then used to synthesize (NH3)Co(DH)2SnPh3 which was
explored as a route to a five coordinate cobaloxime to compare to the five coordinate alkyl cobalt
porphyrin complex. Attempts to drive off the ammonia group by heating were unsuccessful, but
should be revisited in the future. The ammonia cobaloxime was synthesized through the same
one-step procedure as benzyl cobaloxime and a preliminary crystal structure analysis was
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performed. The synthesis of both (NH3)Co(DH)2Cl and (NH3)Co(DH)2SnPh3 is seen in Scheme
5.
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Scheme 5: Synthesis of (NH3)Co(DH)2SnPh3

The (NH3)Co(DH)2Cl was synthesized by reacting dimethylglyoxime, [Co(NH3)5Cl]Cl2,
and ammonium acetate in water and acetic acid. The reaction was heated to 100ºC and acetic
acid was added periodically until no ammonia gas was detectible by litmus. The solid was
collected by vacuum filtration and obtained in 55% yield. The (NH3)Co(DH)2Cl was then reacted
in a one-step procedure with ClSnPh3 and NaBH4 in degassed methanol. The reaction flask was
allowed to stir for several minutes and the solid was collected by vacuum filtration and washed
with ether and hexanes. The product was an orange solid obtained in 50% yield. Its 1H NMR was
consistent with the structure.
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3.1.2

Synthesis of Tetraaryltin Compounds

The hypothesis of this project is that sterically hindering access to the Sn-C bond through
substitution on the para position of the phenyl ring will promote Co-Sn bond cleavage. In order
to test this hypothesis, aryl para-substituted cobaloximes are required. These aryl parasubstituted cobaloximes are achieved through the synthesis of chlorotriaryltin complexes that are
then reacted with (4-t-BuPy)Co(DH)2Cl to produce the desired product.
R
R

R

R
R

R

R

R

Sn
MgBr

Sn

Br

Cl

R

Scheme 6: Retrosynthesis of para-substituted chlorotriaryltin species
The retrosynthetic analysis for the synthesis of these chlorotriaryltin compounds is
represented in Scheme 6. The chlorotriaryltin complex is formed from the redistribution reaction
of the corresponding tetraaryltin compound. This tetraaryltin compound is synthesized from a
Grignard reaction of the bromophenyl compound.
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The first step to this synthetic route is to perform the Grignard reaction. The reaction for
tetra-p-tolyl tin shown in Scheme 7.43 The tetraaryltin compounds that are synthesized from this
step include tetra-C6H4-p-tolyl tin, tetra-C6H4-p-anisole tin, and tetra- C6H4-p-t-butyl tin
represented by the formulas Sn(C6H4-p-tolyl)4, Sn(C6H4-p-OCH3)4, and Sn(C6H4-p-tBu)4
respectively. The synthesis is carried out under nitrogen and begins with the mixing of 4bromotoluene and magnesium turnings in THF. Two crystals of I2 are added to help initiate the
reaction and the flask is brought to reflux for two hours. After the reflux period is complete, the
grayish solution is transferred under nitrogen to another flask and away from any unreacted
magnesium. The flask is then cooled in an ice bath and tin tetrachloride (SnCl4) is added slowly
to the Grignard reagent. The mixture is brought back up to reflux for another twelve hours. At
this point the white solid should form and be able to be filtered out. At times, there was no solid
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and the washing of the solution with 1 M HCl produced a yellow solution. The yellow solution
was then cooled in a freezer for several hours and a white solid product formed and was obtained
through filtration. The solid was rinsed with methanol and 1 M HCl. Several crops of crystals
can be obtained from the solution. The product can be recrystallized by dissolving the solid in
warm toluene and layering with ethanol. The melting point and 1H NMR of the product are
consistent with literature. The synthesis of Sn(C6H4-p-OCH3)4 and Sn(C6H4-p-t-Bu)4 follow the
same procedure and result in white crystalline solids in good yield that have NMR spectra
consistent with their structures. During the preparation of Sn(C6H4-p-OCH3)4 one of the crops of
solid that crashed out was hexa-C6H4-p-anisole ditin, as determined by 1H NMR and melting
point. An attempt to cleave this using halogen to obtain the chlorotriaryltin species was
unsuccessful.
3.1.3

Synthesis of TriaryltinCl Compounds

With the tetraaryl tin species in hand, the redistribution reaction to form the
chlorotriaryltin complexes was attempted. Several unsuccessful methods (Kocheshkov,
Chambers and Scherer, Krause, and a 3:1 Grignard reaction) were explored before a successful
procedure (Jolly) for the redistribution reaction was found.38, 43-45 All attempts at redistribution
were made first using Sn(C6H4-p-tolyl)4 and if successful the other two tetraaryl tin complexes
were investigated.
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Scheme 8: Kocheshkov redistribution synthesis attempt

The first attempt at redistribution involved the Kocheshkov reaction, shown in Scheme
8.38 In a 3:1 mole ratio of Sn(C6H4-p-tolyl)4 to SnCl4, these two compounds are mixed in a test
tube and heated in an oil bath at 205 ºC for three hours. The temperature is then dropped to 160
ºC for another three hours and the solution is then cooled. Upon cooling, a solid should
crystallize and can then be rinsed in boiling ether and filtered. The ether washings are then
concentrated under vacuum and the resulting solid mass filtered. The solid can then be
recrystallized using ethanol. After cooling the solution following its heating to 160 ºC, little
product was observed. After proceeding through with the washings in ether very little product
remained. The 1H NMR showed very little compound and was overwhelmed by mainly solvent
peaks and some impurities. Attempts were also made using SnI4 instead of SnCl4 due to the ease
of handling of the iodide compound, but these attempts were also unsuccessful.
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Scheme 9: Chambers and Scherer redistribution synthetic attempt

The next attempt at the redistribution reaction involved a method from Chambers and
Scherer, seen in Scheme 9.44 This synthetic approach involved a 1:1 mole ratio of Sn(C6H4-ptolyl)4 to iodine. Each reagent was dissolved in chloroform, combined and heated to produce the
iodotriaryltin species. This step never resulted in a pure isolable product. From this step, one
could convert it to the bromotriaryltin complex by dissolving in ether and adding three portions
of 30% NaOH and concentrated HBr. The solutions are dried using sodium sulfate, filtered and
the solvent concentrated using rotary evaporation. The product could be recrystallized from
petroleum ether resulting in about 50% yield.
The third attempt at redistribution involved the Krause method, seen in Scheme 10.45
This method began by dissolving Sn(C6H4-p-tolyl)4 in hot pyridine and stirring. The solution is
then cooled in ice and the solid recrystallizes into fine small crystals that are then reacted with
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Br2 in pyridine added in six aliquots over a few hours. The pyridine and bromobenzene is
removed by vacuum and a brown residue remains. This residue is dissolved in ether and then
reacted with concentrated HCl. The ether solution is filtered and the solvent was removed with a
rotary evaporator to yield the crude chlorotriaryltin product. This crude product is then dissolved
in ether and washed with 30% NaOH. It is then washed with concentrated HCl and purified in
warm ether to yield ClSn(C6H4-p-tolyl)4. The crude product was never obtained through multiple
attempts of this procedure. This is not a viable option for the redistribution of the substituted
phenyl tin compounds.
H 3C

H 3C

dissolve in hot Py
stir
Sn

CH 3
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CH 3

H 3C

CH 3
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H 3C
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Sn

CH 3

wash with conc. HCl
purify in warm ether
CH 3

H 3C

H 3C
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Scheme 10: Krause method for redistribution synthetic attempt
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The next synthetic route investigated was a 3:1 Grignard reaction, seen in Scheme 11.43
The ratio was expected to limit the available Grignard reagent in hopes of leading to only three
of the chlorines being displaced from the SnI4 and producing ISn(C6H4-p-tolyl)3 which can then
be used to synthesize the substituted cobaloxime. The synthesis of the Grignard reagent follows
the same procedure as used in the tetraaryltin syntheses. The next step in the synthesis is similar
as well, except the ratio of the Grignard reagent to the SnI4 has been altered to 1:3. This synthesis
produced many products that were not easily isolated. The main product was still the tetraaryltin
species. This method is not a feasible route to obtain the chlorotriaryltin compounds.
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H 3C

CH 3

H 3C
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Scheme 11: 3:1 Grignard in an attempt to synthesize ClSn(C6H4-p-tolyl)3

The final redistribution method was developed by Jolly and led to the successful
synthesis of ClSn(C6H4-p-tolyl)3 and ClSn(C6H4-p-t-Bu)3, as seen in Scheme 12.38 The
ClSn(C6H4-p-OCH3)3 was not successfully synthesized by this method or any other methods. It is
believed that the methoxy group is being cleaved and other side reactions are occurring,
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preventing the redistribution of the phenyl group. The Jolly procedure is a variation on the
Kocheshkov procedure, but the reaction is done at higher temperatures and the work up of the
solid product is handled differently. The Sn(C6H4-p-tolyl)4 is added to a reaction tube along with
SnCl4 and the tube is heated to 230 ºC slowly over a period of 1.5 hours. The temperature is held
for three hours and then cooled to 100 ºC. When this temperature is reached, the solution is
poured into a beaker and cooled to room temperature. The solid mass is broken up and stirred
with warm ethanol at about 50 ºC. Water is added slowly to crash out the desired product. The
white solid is then filtered and allowed to air dry. This procedure leads to a reasonably pure
product in decent yield, but can be recrystallized to improve the purity of the sample. This
procedure afforded us the desired chlorotriaryltins, ClSn(C6H4-p-tolyl)3 and ClSn(C6H4-p-t-Bu)3.
From here the substituted chlorotriaryltin compounds were reacted using a procedure analogous
to the synthesis of (4-t-BuPy)Co(DH)2SnPh3 discussed above. The reaction of both of these
compounds with (4-t-BuPy)Co(DH)2Cl afforded the desired products of (4-tBuPy)Co(DH)2Sn(C6H4-p-tolyl)3 and (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3. The reactivity of
these substituted cobaloximes was examined through NMR titrations with halogen, described in
the next section.

1) SnCl4
o
2) 230 C
Sn

o

3) cool to 100 C
4) cool to RT
5)warm EtOH
6) H2O

Sn
Cl

C6H4-p-tolyl: 61%
C6H4-p-t-Bu: 67%

Scheme 12: Jolly procedure for the successful redistribution of Sn(C6H4-ptolyl)4 to ClSn(C6H4-p-tolyl)3
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3.2 X-ray Structure Analysis of Cobaloxime Tin Complexes
3.2.1

X-ray Analysis of (4-t-BuPy)Co(DH)2Sn(C6H4-p-tolyl)3

A crystal structure of (4-t-BuPy)Co(DH)2Sn(C6H4-p-tolyl)3 was determined. An ORTEP
drawing of the structure is shown in Figure 4. The crystal data is represented in Table 2. Table 3
contains the data collection and structure refinement parameters and Table 4 contains selected
interatomic distances and bond angles for (4-t-BuPy)Co(DH)2Sn(C6H4-p-tolyl)3. The compound
crystallizes in the centrosymmetric triclinic space group P-1 with two compounds in the unit cell.
The cobalt is a six coordinate octahedral atom that is connected to the four donor nitrogen atoms

Figure 4. ORTEP drawing of (4-t-BuPy)Co(DH)2Sn(C6H4-p-tolyl)3. Perspective view of the
molecular structure of one of the two crystallographic independent molecules of (4-tBuPy)Co(DH)2Sn(C6H4-p-tolyl)3 with the atom labeling scheme for the non-hydrogen
atoms. The thermal ellipsoids are scaled to enclose 30% probability.
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from dimethylglyoxime (DMG) in the equatorial plane and to the tin and nitrogen of the 4-tBupyridine in the axial positions. Each of the DMG ligands is chelated in a bidentate fashion
through the donor nitrogen atoms to the cobalt center. The DMG ligands are connected to each
other through two bridging O—H⸱⸱⸱O hydrogen bonds.
The equatorial Co-N bonds have interatomic distances that range from 1.874(3) – 1.880(3) Å.
This is comparable to the equatorial Co-N interatomic distances for the coenzyme B12 (~1.90 Å),
vitamin B12 (~1.92 Å), and alkyl cobaloxime (~1.88 Å).7, 14 The alkyl cobaloxime that is
referenced is the first alkyl cobaloxime studied by Lenhert in 1967, PyCo(DH)2CH2COOCH3.
The equatorial Co-N bonds for CoIII(OEP)SnPh3 are slightly longer (1.962 – 1.975 Å) than (4tBuPy)Co(DH)2Sn(C6H4-p-tolyl)3.26
The axial Co-N bond for the 4-t-BuPy is 2.063(3) Å. This is similar to the bond distances in
vitamin B12 (1.97 – 2.06 Å) and alkyl cobaloxime (~2.04 Å), but is shorter than the axial Co-N
bond in coenzyme B12 (2.24 Å).7, 14 The increased length in the axial Co-N bond in the coenzyme
is believed to come from the cobaloxime having a slightly greater positive charge on the cobalt
center than in the coenzyme.
The axial Co-Sn bond for the Sn(p-tolyl)3 is 2.5746(6) Å. It is slightly longer than the axial
Co-Sn bond from CoIII(OEP)SnPh3 (2.510 Å), and is much longer than the axial Co-C bonds
from coenzyme B12 (2.03 Å), vitamin B12 (1.92 Å), and alkyl cobaloxime (2.04 Å). 7, 14, 26 The
large bond distance for Co-Sn in (4-t-BuPy)Co(DH)2Sn(C6H4-p-tolyl)3 likely arises from the
trans effect of the pyridine.32
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Table 2. Crystal data for (4-t-BuPy)Co(DH)2Sn(C6H4-p-tolyl)3

Chemical formula
Formula weight
Temperature
Wavelength
Crystal size
Crystal system
Space group
Unit cell dimensions

Volume
Z
Density (calculated)
Absorption coefficient
F(000)

C38H48CoN5O4Sn
816.43
296(2) K
0.71073 Å
0.112 x 0.156 x 0.408 mm
triclinic
P -1 (No. 2)
a = 13.2949(5) Å
α = 107.1983(13)°
b = 17.7508(7) Å
β = 91.6597(13)°
c = 18.2240(7) Å
γ = 107.6992(12)°
3
3880.5(3) Å
4
1.397 g/cm3
1.115 mm-1
1680

Table 3. Data collection and structure refinement for (4-t-BuPy)Co(DH)2Sn(C6H4-p-tolyl)3
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Coverage of independent
reflections
Absorption correction
Max. and min. transmission
Refinement method
Refinement program
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices
Largest diff. peak and hole

2.75 to 27.50°
-17 ≤ h ≤ 16, -23 ≤ k ≤ 23, -23 ≤ l ≤ 23
97231
17647 [R(int) = 0.0576]
99.0%
multi-scan
0.885 and 0.659
Full-matrix least-squares on F2
SHELXL-2013 (Sheldrick, 2013)
17647 / 6 / 950
1.103
11275 data; I>2σ(I)
R1 = 0.0647, wR2 = 0.0880
all data
R1 = 0.1061, wR2 = 0.0956
- 3
1.054 and -0.657 e /Å
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Table 4: Selected interatomic distances (Å) and bond angles (°) for (4-t-BuPy)Co(DH)2Sn(C6H4p-tolyl)3
Selected Interatomic Distances
Sn1-C25
2.153(4)
Sn1-C18
2.170(4)
Co1-N4
1.874(3)
Co1-N3
1.875(3)
Co1-N5
2.063(3)

Sn1-C32
Sn1-Co1
Co1-N2
Co1-N1

2.163(4)
2.5746(6)
1.875(3)
1.880(3)

Selected Bond Angles
C25-Sn1-C32
105.99(17)
C32-Sn1-C18
101.28(16)
C32-Sn1-Co1
119.39(12)
N4-Co1-N2
175.45(14)
N2-Co1-N3
99.20(15)
N2-Co1-N1
80.77(15)
N4-Co1-N5
92.56(13)
N3-Co1-N5
91.78(13)
N4-Co1-Sn1
89.28(10)
N3-Co1-Sn1
90.13(10)
N5-Co1-Sn1
177.52(9)

C25-Sn1-C18
C25-Sn1-Co1
C18-Sn1-Co1
N4-Co1-N3
N4-Co1-N1
N3-Co1-N1
N2-Co1-N5
N1-Co1-N5
N2-Co1-Sn1
N1-Co1-Sn1

106.08(17)
112.52(11)
110.32(11)
81.44(15)
98.24(14)
175.54(14)
91.92(13)
92.68(13)
86.22(10)
85.42(10)

3.2.2

Preliminary X-ray Analysis of (NH3)Co(DH)2SnPh3

The crystal structure was also obtained for the cobaloxime with ammonia as a labile base,
NH3Co(DH)2SnPh3. This compound was synthesized in an effort to obtain a five coordinate
cobaloxime through the dissociation of the ammonia. The goal of this synthesis was to develop a
cobaloxime with the same coordination environment as the organotin porphyrin complexes to see
if this change in the structure of the cobaloxime would result in clean cleavage of the Co-Sn
bond by oxidation with halogen. This compound was synthesized by a one-step cobaloxime
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procedure described in the experimental, but efforts to obtain the five coordinate cobaloxime by
heating to 60-70 ºC to drive off the NH3 have been unsuccessful.
The quality of the crystal structure analysis of this complex, although limited, was sufficient
to verify the atom connectivity of this ammonia adduct. The cobalt complex, as depicted in
Figure 5, is six coordinate with the octahedral coordination sphere containing ammonia, tin and
four donor nitrogens from the two dimethylglyoxime ligands. The ammonia and tin are located
in the axial positions with the four donor nitrogens of the dimethylglyoxime ligands in the
equatorial plane. The analysis showed that the lattice contained a disordered solvent. The
bridging hydrogens that connect the two dimethylglyoxime ligands through O-H-O hydrogen
bonds were unable to be resolved in this structure. The crystal structure is not resolved well
enough for publication, but is sufficient to demonstrate the connectivity of the
NH3Co(DH)2SnPh3.

Figure 5: ORTEP drawing of (NH3)Co(DH)2SnPh3. Perspective view of
the molecular structure of (NH3)Co(DH)2SnPh3, where DH =
ONC(Me)=C(Me)NOH, with the atom labeling scheme for the nonhydrogen atoms. The thermal ellipsoids are scaled to enclose 30%
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3.3 Halogen Cleavage Titrations
This section discusses the halogen cleavage reactions of the synthesized cobaloximes. The
Co(OEP)SnPh3 cleaves the Co-Sn bond cleanly upon addition of halogen, as seen in Scheme 3.26
The (4-t-BuPy)Co(DH)2SnPh3 was seen to form multiple products upon the addition of halogen
and did not cleave the Co-Sn bond cleanly. Instead, the cleavage of the Sn-C bond of the phenyl
ring through electrophilic aromatic substitution was observed, as seen in Scheme 3. The purpose
of this project is to develop a system for the cobaloxime, through tuning its environment, that
will allow it to exhibit clean homolytic Co-Sn bond cleavage. If this is achieved, the system may
help us to understand the differences in reactivity of the porphyrins and cobaloximes. The
hypothesis of this project was that substitution on the para position of the phenyl rings attached
to the tin could change the donor strength and may promote Co-Sn bond cleavage. The para
substituted cobaloximes were successfully synthesized and the halogen cleavage reactions
discussed in this section will test this hypothesis.
The following halogen cleavage reactions have been performed to date: (Py)Co(DH)2SnPh3,
(4-t-BuPy)Co(DH)2SnPh3, (NH3)Co(DH)2SnPh3, (4-CNPy)Co(DH)2SnPh3, (4-tBuPy)Co(DH)2Sn(C6H4-p-tolyl)3, and (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3. A former group
member also ran a halogen cleavage titration with (4-t-BuPy)Co(DH)2Sn(n-Bu)3. The halogen
cleavage titrations were performed on the NMR scale using I2 or Br2 and measuring the 1H NMR
spectra for every determined amount of equivalents. The (4-t-BuPy)Co(DH)2Sn(n-Bu)3 did
exhibit clean cleavage of the Sn-Co bond, but may not provide enough information about the
differences in the porphyrin and cobaloxime system since it is an alkyl tin ligand and not an
aryltin ligand attached to the cobalt center. The alkyl tin does not translate well to the lead
analogue due to toxicity issues, so comparison across group 14 elements is better served by the
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aryl tin ligand cobaloximes. All of the triaryltin cobaloximes exhibited cleavage of the Sn-C
bond instead of clean cleavage of the Co-Sn bond. Although all of these cobaloximes showed
multiple products developing in the NMR as the halogen was added, the halogen titration of (4-tBuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 had less overlap due to the p-t-Bu group. To provide an
example of the nature of the halogen cleavage reactions for the cobaloxime tin complexes, the
experimental results are described for the bromine titration and the corresponding 1H NMR
spectra at room temperature for (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 are displayed in Figures 615.
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Figure 6: Initial H NMR bromine cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 in C6D6
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Figure 7: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 H NMR in C6D6. The O—
H⸱⸱⸱O bridging region for 0 and 0.25 equivalents of Br2.
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Figure 8: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 H NMR in C6D6. The O—H⸱⸱⸱O
bridging region for 0.5 and 0.75 equivalents of Br2.
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Figure 9: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 H NMR in C6D6. The O—H⸱⸱⸱O
bridging region for 1 and 2 equivalents of Br2.
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Figure 10: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 H NMR in C6D6. The alkyl region 0 eq Br2.
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Figure 11: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 H NMR in C6D6. The alkyl region 0.25 eq Br2.
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Figure 12: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 H NMR in C6D6. The alkyl region 0.5 eq
Br2.

45

0.75 Eq

*
*
* Starting Material

*

Br

*
*
*

*

1

Figure 13: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 H NMR in C6D6. The alkyl region 0.75 eq Br2.
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Figure 14: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 H NMR in C6D6. The alkyl region 1 eq Br2.
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Figure 15: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 H NMR in C6D6. The alkyl region 2 eq Br2.
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Figure 16: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 H NMR in C6D6. The aromatic region for 0
equivalents of Br2.
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Figure 17: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 H NMR in C6D6. The aromatic region for 0.25
equivalents of Br2.
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Figure 18: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 H NMR in C6D6. The aromatic region for 0.5
equivalents of Br2.
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Figure 19: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 H NMR in C6D6. The aromatic region for 0.75
equivalents of Br2.
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Figure 20: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 H NMR in C6D6. The aromatic region for 1
equivalent of Br2.

53

2 Eq

* Starting Material

*
*

* 13C Satellites
*

Br

*

*

*

*

1

Figure 21: Bromine Cleavage of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 H NMR in C6D6. The aromatic
region for 2 equivalents of Br2.
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The (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 was dissolved in C6D6 and the concentration
determined. Seven test tubes received 1 mL of the cobaloxime solution and bromine was added
to the test tubes in order to obtain samples with 0, 0.25, 0.5, 0.75, 1, and 2 eq. of bromine. An
aliquot of 100 µL was removed from each sample to prepare a GCMS sample in benzene. The
remaining 900 µL of solution went into an NMR tube and the proton spectra was obtained. The
Figures 6-15 are broken into the different regions of the spectra for each equivalent of bromine.
Figure 6 provides the overall structure (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3 and the initial
spectra for the compound. Figures 7 – 9 cover the O—H⸱⸱⸱O region around 19 ppm, Figures 10 –
12 cover the alkyl region from 0 – 2.5 ppm, and Figures 13 – 15 cover the aromatic region from
6 – 9 ppm.
Figure 6 displays the initial structure of (4-t-BuPy)Co(DH)2Sn(C6H4-p-t-Bu)3. This
compound has very distinct peaks and is more resolved than some of the other cobaloximes that
tend to have overlapping and crowding in the aromatic region. The compound has 8 distinct
peaks corresponding to the 75 hydrogens in the structure. In the alkyl region, the three peaks
correspond to the t-Bu group of the pyridine (0.64 ppm, s, 9 H), the t-Bu groups on the phenyl
rings attached to the tin (1.22 ppm, s, 27 H), and the methyl groups on the DMG ligand (1.63
ppm, s, 12 H). In the aromatic region there are four peaks that correspond to the β protons of the
pyridine ring (6.56-6.54 ppm, dd, 2 H), the m-H of the phenyl rings (7.28-7.26 ppm, dd, 6 H), the
o-H of the phenyl ring (7.95-7.93 ppm, dd, 6 H), and the α protons of the pyridine ring (8.938.91 ppm, dd, 2 H). The final region is the O—H⸱⸱⸱O hydrogen bonds that appear at 19.74 ppm
as a broad singlet of 2 H. These NMR peaks, integrations and chemical shifts are consistent with
the structure. There is also a strong solvent peak for C6D6 at 7.16 ppm with 13C satellites
appearing at 7.36 and 6.96 ppm, but no other unexpected peaks are present.
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Scheme 13: Proposed Reaction of Halogen with Triaryltin Cobaloxime

Figures 7 through 9 contain the O—H⸱⸱⸱O bonding region around 19.7 ppm for 0, 0.25, 0.5,
0.75, 1, and 2 equivalents of bromine. The initial peak for the bridging hydrogen is at 19.74 ppm.
At 0.25 equivalents of bromine, two more bridging hydrogen peaks are present at 19.44 and
19.18 ppm. These new peaks correspond to a new cobaloxime being formed through cleavage of
a C-Sn bond by the halogen. At 0.5 equivalents of bromine, the starting compound peak at 19.74
has decreased significantly and a new peak at 18.86 ppm is present. At 0.75 equivalents of
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bromine, the 19.74 and 19.44 ppm peaks have almost disappeared and the 19.18 and 18.86 ppm
peaks have increased. At 1 equivalent of bromine, the 19.74 and 19.44 ppm peaks are completely
gone and the 19.18 ppm peak has decreased in relation to the 18.86 ppm peak. At 2 equivalents
of bromine, the only peak that remains is the 18.86 ppm peak. The 19.74 ppm corresponds to the
initial cobaloxime and the new peaks 19.44, 19.18, and 18.86 ppm correspond to the new
cobaloxime products. Through GCMS studies it is determined that 1-bromo-4-t-butylbenzene is
the main product formed upon addition of bromine and the concentration of the peak increases as
the equivalents of bromine increase. This product would arise from the cleavage of the Sn-C
bond by bromine as seen in Scheme 13 below. The peaks corresponding to 19.44, 19.18 and
18.86 ppm arise from the Sn-C cleavage and production of Ar-Br bonds.
Figures 10 – 15 contain the 1H NMR spectra for the alkyl region. The initial peaks are the tBu group of the pyridine (0.64 ppm, s, 9 H), the t-Bu groups on the phenyl rings attached to the
tin (1.22 ppm, s, 36 H), and the methyl groups on the DMG ligand (1.63 ppm, s, 12 H). This
region behaves similar to the bridging hydrogen region upon addition of bromine. The clearest
example in this region is the t-butyl peak of the phenyl rings. The initial peak is at 1.22 ppm and
upon addition of 0.25 equivalents of bromine, three new peaks are observed (1.19, 1.13, 1.06
ppm). For the 0.5, 0.75, and 1 equivalents of bromine spectra all four peaks are still visible, but
the more downfield peaks have significantly decreased in intensity and the 1.06 ppm peak is the
most dominant. After 2 equivalents of bromine, the dominant peak is 1.06 ppm and the initial
peak of 1.22 ppm and the 1.13 ppm peaks are still observed, but the 1.18 ppm peak has
disappeared. The 1.06 ppm peak corresponds to the tert-butyl group of the 1-bromo-4-tbutylbenzene organic product that is formed from the Sn-C bond cleavage. This peak increases in
intensity as the equivalents of bromine increase and can indicate that the three bonds of the Sn-C
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may be cleaved in succession upon addition of the bromine and lead to an increasing amount of
BrAr cleavage product being present. A proposed set of reactions for this compound is seen in
Scheme 13 with a focus on Sn-C cleavage. The three new cobaloxime products seen in the
bridging region could be consistent with the formation of (4-t-BuPy)Co(DH)2SnAr2Br, (4-tBuPy)Co(DH)2SnArBr2 and (4-t-BuPy)Co(DH)2SnBr3 as the bromine titration progresses.
Another option could be that Co-Sn bond cleavage may be possible after the cleavage of some of
the Sn-C bonds due to changes in the electronic environment of the tin ligand. The exact
products for these peaks can be suggested, but cannot be confirmed without the synthesis and
characterization of the possible intermediates outlined in Scheme 13. One can infer that since the
Sn-C bond is preferentially cleaved, the Sn-C bond cleavage with halogen is more facile than the
Co-Sn bond with this set of compounds.
Figures 16 – 21 contain the aromatic region for the halogen cleavage titration. This
spectral region gets more crowded, but the same behavior can be seen with the pyridine and
phenyl peaks. Several new products are growing into the aromatic region of the cobaloxime as
the bromine is added, but as the titration progresses some peaks are harder to resolve. Although
this spectral region is not as clear as the bridging hydrogen and alkyl regions, we can still
monitor the formation of the cleavage product 1-bromo-4-t-butylbenzene. The cleavage product
has aromatic peaks 7.29-7.27 and 6.91-6.89 ppm. These peaks behave similarly to the t-Bu peak
in the alkyl region and increase in intensity as the bromine is added in increasing equivalents.
This preference for the Sn-C bond cleavage is demonstrated in this region as well and the
changes in the spectra are consistent with the previously discussed proposed reaction Scheme 13.
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4.0 Conclusions
Several six-coordinate cobaloxime compounds containing a triaryltin ligand were
synthesized and characterized. The susceptibility of these cobaloximes to halogen cleavage was
investigated. The multiple products formed through these halogen cleavage reactions indicates
that the Co-Sn bond is not readily cleaved cleanly for these cobaloximes, unlike the reactivity
observed with the alkyl and tin porphyrin complexes. The cobaloximes react with the halogens to
first cleave the Sn-C bonds through electrophilic aromatic substitution, which indicates that the
Sn-C bond cleavage is more facile than the Co-Sn cleavage for this set of compounds. The
alteration of the para substituent on the phenyl rings to change donor ability of the Sn-C bonds
and alter the electronic environment in attempts to promote Co-Sn cleavage was unsuccessful.
The ultimate goal of this work is to find a cobaloxime system, containing a triaryltin ligand, that
will have clean cleavage of the Co-Sn bond so it can be compared to the porphyrin system to
better understand the differences in reactivity between these two vitamin B12 analogues.
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